Ocean waves are a vast and steady source of renewable energy, but capturing their power efficiently has long frustrated engineers. A researcher at The University of Osaka has now explored a bold new ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...

Temperatures reached record highs in multiple states on Wednesday, as a heat wave that has been scorching the West since last week expanded into the middle of the country. The unusually warm weather ...

Primary Wave Music has announced a “definitive” agreement to acquire Kobalt, one of the world’s largest independent music publishing and technology platforms, from Francisco Partners, creating a ...

This is read by an automated voice. Please report any issues or inconsistencies here. The recent trio of extreme wildfires, record-breaking rains and historic heat can all be tied to climate change, ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

WASHINGTON, March 2 (Reuters) - The "big wave" is yet ‌to come in the war with Iran, U.S. President Donald Trump told CNN on Monday, adding that Washington did not know who ⁠the country's new leader ...

President Donald Trump told CNN in a nine-minute phone interview Monday morning that the US military is “knocking the crap” out of Iran – but the “big wave” is yet to come. “We’re knocking the crap ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...